Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma
Clinical trial NCT04301843 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04301843
- Sponsor
- Giselle Sholler
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-25
- Primary completion
- 2028-10-01
- Enrollment
- 131
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.